Ostrov DA - Search Results

1

Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation.

Michels AW, Ostrov DA, Zhang L, Nakayama M, Fuse M, McDaniel K, Roep BO, Gottlieb PA, Atkinson MA, Eisenbarth GS. Michels AW, et al. Among authors: ostrov da. J Immunol. 2011 Dec 1;187(11):5921-30. doi: 10.4049/jimmunol.1100746. Epub 2011 Oct 31. J Immunol. 2011. PMID: 22043012 Free PMC article.

2

New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity.

Michels AW, Ostrov DA. Michels AW, et al. Among authors: ostrov da. J Allergy Clin Immunol. 2015 Aug;136(2):252-7. doi: 10.1016/j.jaci.2015.06.024. J Allergy Clin Immunol. 2015. PMID: 26254052 Free PMC article. Review.

3

Sulfatide Preserves Insulin Crystals Not by Being Integrated in the Lattice but by Stabilizing Their Surface.

Buschard K, Bracey AW, McElroy DL, Magis AT, Osterbye T, Atkinson MA, Bailey KM, Posgai AL, Ostrov DA. Buschard K, et al. Among authors: ostrov da. J Diabetes Res. 2016;2016:6179635. doi: 10.1155/2016/6179635. Epub 2016 Feb 14. J Diabetes Res. 2016. PMID: 26981544 Free PMC article.

4

Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes.

Ostrov DA, Alkanani A, McDaniel KA, Case S, Baschal EE, Pyle L, Ellis S, Pöllinger B, Seidl KJ, Shah VN, Garg SK, Atkinson MA, Gottlieb PA, Michels AW. Ostrov DA, et al. J Clin Invest. 2018 May 1;128(5):1888-1902. doi: 10.1172/JCI97739. Epub 2018 Apr 3. J Clin Invest. 2018. PMID: 29438107 Free PMC article.

5

Rationally designed small molecules to prevent type 1 diabetes.

Ostrov DA, Gottlieb PA, Michels AW. Ostrov DA, et al. Curr Opin Endocrinol Diabetes Obes. 2019 Apr;26(2):90-95. doi: 10.1097/MED.0000000000000470. Curr Opin Endocrinol Diabetes Obes. 2019. PMID: 30694829 Free PMC article. Review.

6

Identification of drug-specific public TCR driving severe cutaneous adverse reactions.

Pan RY, Chu MT, Wang CW, Lee YS, Lemonnier F, Michels AW, Schutte R, Ostrov DA, Chen CB, Phillips EJ, Mallal SA, Mockenhaupt M, Bellón T, Tassaneeyakul W, White KD, Roujeau JC, Chung WH, Hung SI. Pan RY, et al. Among authors: ostrov da. Nat Commun. 2019 Aug 8;10(1):3569. doi: 10.1038/s41467-019-11396-2. Nat Commun. 2019. PMID: 31395875 Free PMC article.

7

T cell receptor antagonism mediated by interaction between T cell receptor junctional residues and peptide antigen analogues.

Ostrov D, Krieger J, Sidney J, Sette A, Concannon P. Ostrov D, et al. J Immunol. 1993 May 15;150(10):4277-83. J Immunol. 1993. PMID: 8482836

8

Structural features of MHC class I molecules that might facilitate alternative pathways of presentation.

Hansen T, Balendiran G, Solheim J, Ostrov D, Nathenson S. Hansen T, et al. Immunol Today. 2000 Feb;21(2):83-8. doi: 10.1016/s0167-5699(98)01426-1. Immunol Today. 2000. PMID: 10652466 Review.

9

Molecular recognition of human CD1b antigen complexes: evidence for a common pattern of interaction with alpha beta TCRs.

Melián A, Watts GF, Shamshiev A, De Libero G, Clatworthy A, Vincent M, Brenner MB, Behar S, Niazi K, Modlin RL, Almo S, Ostrov D, Nathenson SG, Porcelli SA. Melián A, et al. J Immunol. 2000 Oct 15;165(8):4494-504. doi: 10.4049/jimmunol.165.8.4494. J Immunol. 2000. PMID: 11035089

10

Immunobiological analysis of TCR single-chain transgenic mice reveals new possibilities for interaction between CDR3alpha and an antigenic peptide bound to MHC class I.

Zhang W, Honda S, Wang F, DiLorenzo TP, Kalergis AM, Ostrov DA, Nathenson SG. Zhang W, et al. Among authors: ostrov da. J Immunol. 2001 Oct 15;167(8):4396-404. doi: 10.4049/jimmunol.167.8.4396. J Immunol. 2001. PMID: 11591764

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters